Shire sheds Dermagraft at $650m loss
January 20, 2014Sales and Marketing Organogenesis, Shire, dermagraft
Shire has offloaded its Dermagraft business to Organogenesis just three years after purchasing the company. Given the sale has come …
Problems and solutions
January 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing adams, culture, pharma, problems, social media
Not long ago I was asked to be involved in a project that filmed UK-based pharma journalists in order to …
New chair for British Generic Manufacturers Association
January 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing bgma, thomas broeer
Thomas Broeer has been elected as chair of 





The British Generic Manufacturers Association (BGMA). Broeer, managing director of Kent Pharmaceuticals, …
Europe nod for Gilead HCV pill
January 20, 2014Sales and Marketing FDA, Gilead, HCV, hep C, sofosbuvir, sovaldi
Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has been given the green light by the European Commission, just a …
Google to use contact lens as diabetes monitor
January 17, 2014Medical Communications, Sales and Marketing calico, contact, diabetes, google, lens
Google is developing a new type of contact lens designed to help patients with diabetes measure their blood sugar levels. …
Actavis: China is ‘too risky’
January 17, 2014Sales and Marketing Actavis, China, bribery, generics, risky
The boss of generic drug manufacturer Actavis says his company is pulling out of China because the business environment there …
Technology to dominate 2014 for businesses
January 17, 2014Medical Communications 2014, Cloud Computing, IT, digital, e-zest, technology
2014 will see healthcare businesses and governments rapidly absorb new technologies in order to enhance user experience and foster innovation …
Ian Gilham appointed chairman of the board at Horizon Discovery




January 17, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development Gilham, Horizon Discovery
Research tools firm Horizon Discovery has appointed Dr Ian Gilham as chairman of its board of directors.



 Gilham’s healthcare industry …
Gene trial ‘restores sight’
January 17, 2014Research and Development, Sales and Marketing NHS, Oxford University Hospitals NHS Trust, choroideremia, eyes
A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …
FDA issues online guidance
January 16, 2014Manufacturing and Production, Medical Communications, Sales and Marketing FDA, Twitter, digital, online, ugc
The FDA has issued new guidance on what online promotional material pharma needs to show it. The document is out …
Reprieve for Merck’s vorapaxar
January 16, 2014Sales and Marketing FDA, Merck, heart, vorapaxar
An FDA committee has voted that Merck’s troubled heart drug vorapaxar should be approved by the US regulator. The advisory …
Heptares appoints Tim Tasker as chief medical officer


January 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heptares, tim tasker
Drug development firm Heptares Therapeutics has appointed Dr Tim Tasker as its chief medical officer (CMO) and VP of Development. …
Doctor-pharma relationships ‘can’t be trusted’
January 16, 2014Sales and Marketing BMJ, NHS, doctors, pharma
A US doctor has warned that patients will lose trust in healthcare professionals if they do not disclose the extent …
Plastic surgery app for girls pulled from iTunes
January 15, 2014Medical Communications Apple, app, digital, itunes, surgery
Experts have welcomed a decision to axe an app that encourages young girls to have plastic surgery saying that it …
GSK has Tafinlar ‘breakthrough’
January 15, 2014Sales and Marketing Cancer, FDA, GSK, NSCLC, Tafinlar
GlaxoSmithKline is on a roll, with its cancer drug Tafinlar given breakthrough therapy designation by the FDA in lung cancer …
AZ bullish on its future – but analysts wary
January 15, 2014Sales and Marketing AstraZeneca, Roche, analysts, jp morgan
AstraZeneca is combating fears over its long-term future by assuring investors that it has the pipeline and the tenacity to …
ICON hires Dr Steve Cutler as chief operating officer
January 15, 2014Manufacturing and Production, Research and Development, Sales and Marketing ICON, cutler
Clinical research organisation ICON has appointed Dr Steve Cutler to the newly created position of chief operating officer (COO).
UK cancer figures rise
January 15, 2014Research and Development, Sales and Marketing Cancer, England, NHS, research uk
More people are being diagnosed with cancer than ever before, according to figures from Cancer Research UK – as an …
Bayer and Regeneron to co-develop wet AMD antibody
January 14, 2014Research and Development, Sales and Marketing Bayer, Eylea, Regeneron, pdgfr-beta, wet AMD
Bayer and Regeneron are co-developing an antibody to the Platelet Derived Growth Factor Receptor Beta (PDGFR-beta) as a combination therapy …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
